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Abstract 
 Effect of Diocleinae lectins on bacteria and fungi planktonic and sessile cells 
Microorganisms have been showing augmented resistance towards antimicrobials, 
being microbial resistance, nowadays, one of the biggest problems of public health. Thus, 
there is an increasing interest in the development of new strategies of microbial control, 
namely the ones based on natural products, especially from plants, such as lectins. So, it is of 
utmost importance to test new antimicrobial compounds, especially with a wide range, against 
bacteria and fungi. Therefore, the main aim of this thesis was to evaluate the effect of new 
lectins against both Gram-negative and Gram-positive bacteria, as well, as yeast. Moreover, 
these lectins were assessed against planktonic and sessile cells. 
Four Diocleinae lectins: Canavalia ensiformis, Canavalia brasiliensis, Canavalia 
maritima and Canavalia boliviana, were used in this study. Their effect was assessed against 
two Gram-positive bacteria (Staphylococcus epidermidis, Staphylococcus aureus), two Gram-
negative bacteria (Pseudomonas aeruginosa, Klebsiella oxytoca) and two yeasts (Candida 
albicans and Candida tropicalis). The effect was evaluated on microbial planktonic growth, 
early-stage adhesion, on biofilm biomass and biofilm viable cells.  
The four lectins showed different activities (inhibitory or stimulatory effect) on 
planktonic growth, early-stage adhesion and biofilm formation, for the same microorganism. In 
general, the inhibitory effect of lectins was most notable on planktonic growth than on biofilm 
formation. Although there are few differences in the inhibitory capacity of lectins, K. oxytoca 
can be considered the microorganism that suffered lower inhibition. Interestingly, the results 
demonstrated that activities of lectins tested were species-dependent, namely, their action 
was different between the two Gram-negative species, as well as the two Gram-positive and 
the two yeasts. This highlights that the interaction between the lectin and the cell is of high 
specificity. 
So, in conclusion, due to the specificity of the lectins assayed, it could be of major 
interest to improve their potential (synergic effect) by using more than one at the same time 
or combined with conventional antimicrobial agents.  
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Resumo 
Efeito de lectinas da subfamília Diocleinae em células bacterianas e fúngicas, no 
estado planctónico e séssil 
A resistência exibida pelos microrganismos a agentes anti-microbianos representa um 
dos maiores problemas que a Saúde pública enfrenta na atualidade. Desta forma, tem-se 
denotado um aumento do interesse pelo desenvolvimento de novas estratégias para o 
controlo microbiano que passam pela procura de produtos naturais, especialmente oriundos 
de plantas, como as lectinas. A utilização de novos compostos antimicrobianos que possam ser 
usados contra uma vasta gama de bactérias e fungos, revela-se de extrema importância. 
Assim, o objectivo desta dissertação consistiu na verificação do efeito da aplicação de novas 
lectinas em bactérias Gram-positivas e Gram-negativas, bem como em leveduras. Além disso, 
estas lectinas foram testadas em células, quer no estado planctónico e quer no estado séssil.  
Neste estudo foram utilizadas quatro lectinas da subfamília Diocleinae: Canavalia 
ensiformis, Canavalia brasiliensis, Canavalia maritima and Canavalia boliviana. O seu efeito foi 
avaliado em duas bactérias Gram-positivas (Staphylococcus epidermidis, Staphylococcus 
aureus), duas bactérias Gram-negativas (Pseudomonas aeruginosa, Klebsiella oxytoca) e em 
duas leveduras (Candida albicans and Candida tropicalis). A acção das lectinas foi analisada no 
crescimento planctónico, na adesão inicial, na biomassa de biofilme e no número de células 
cultiváveis dos biofilmes.   
As quatro lectinas demonstraram atividades distintas (efeito inibitório e de 
estimulação) no crescimento planctónico, na adesão inicial e na formação de biofilme, para o 
mesmo microrganismo. Em geral, o efeito inibitório das lectinas foi mais notório no 
crescimento planctónico do que na formação de biofilme. Apesar da capacidade inibitória das 
lectinas não diferir muito entre os microrganismos, a bactéria K. oxytoca foi a menos sensível 
aos compostos usados.  
Estes resultados demonstraram que a atividade das lectinas testadas se encontra 
dependente da espécie, sendo a sua ação diferente entre as duas espécies Gram-positivas, as 
duas Gram-negativas e as duas leveduras utilizadas. Corrobora-se, assim, a elevada 
especificidade existente na interação entre as lectinas e as células. 
Em suma, dada a especificidade das lectinas testadas, pensa-se que estas poderão ter 
um potencial acrescido se utilizadas em conjunto ou combinadas com agentes antimicrobianos 
convencionais.  
 
 
  
 
 
Contents 
ix 
 
Contents 
 
Acknowledgements ...................................................................................................................... iii 
Abstract ......................................................................................................................................... v 
Resumo ......................................................................................................................................... vii 
Contents ........................................................................................................................................ ix 
List of Figures ................................................................................................................................ xi 
List of Tables ................................................................................................................................ xiii 
List of Abbreviations ..................................................................................................................... xv 
 
Chapter 1 | Introduction ............................................................................................................... 1 
1.1. Contextualization and objectives ...................................................................................... 2 
1.2. Literature review ............................................................................................................... 3 
1.2.1. Microorganisms ......................................................................................................... 3 
Staphylococcus epidermidis and Staphylococcus aureus ...................................................... 3 
Klebsiella oxytoca and Pseudomonas aeruginosa ................................................................. 4 
Candida albicans and Candida tropicalis............................................................................... 4 
1.2.2. Structure and components of the cell wall ............................................................... 5 
1.2.2.1. Bacterial cell wall ................................................................................................... 5 
Gram-positive bacteria .......................................................................................................... 5 
Gram-negative bacteria......................................................................................................... 6 
1.2.2.2. Fungal cell wall ...................................................................................................... 7 
1.2.3. Cell adhesion as virulence factor............................................................................... 7 
1.2.4. Biofilms ...................................................................................................................... 8 
1.2.4.1. Biofilm development ........................................................................................... 10 
1.2.4.2. Biofilm resistance to antimicrobial agents .......................................................... 12 
Restricted penetration ........................................................................................................ 12 
Slow growth rate ................................................................................................................. 12 
Persisters and phenotypic variants ..................................................................................... 13 
1.2.5. Natural antimicrobial agents ................................................................................... 13 
1.2.5.1. Lectins.................................................................................................................. 14 
Lectin sources ...................................................................................................................... 15 
Biological activities and applications of lectins ................................................................... 16 
Contents 
x 
 
Chapter 2 | Materials and Methods ........................................................................................... 21 
2.1. Lectins origin ................................................................................................................... 22 
2.2. Lectins stock solution ...................................................................................................... 22 
2.3. Microorganisms and culture conditions ......................................................................... 22 
2.4. Lectin antimicrobial activity ............................................................................................ 23 
2.5. Lectin effect on early-stage adhesion ............................................................................. 23 
2.6. Biofilm prevention ........................................................................................................... 24 
2.6.1. Biofilm biomass quantification ................................................................................ 24 
2.6.2. Biofilm viable cells enumeration ............................................................................. 25 
2.7. Statistical analysis............................................................................................................ 25 
Chapter 3 | Results ...................................................................................................................... 27 
3.1. Bacterial and yeast planktonic growth ............................................................................ 28 
3.2. Bacteria and yeast early-stage adhesion......................................................................... 30 
3.3. Bacteria and yeast biofilm mass ...................................................................................... 30 
3.4. Bacteria and yeast viable biofilm-entrapped cells .......................................................... 33 
3.5. Summary table of results ................................................................................................ 33 
Chapter 4 | Discussion ................................................................................................................ 37 
Chapter 5 | Conclusion and suggestions for future research ..................................................... 43 
References ................................................................................................................................... 45 
 
 
 
List of Figures  
xi 
 
List of Figures 
 
Figure 1. Representative scheme of Gram-positive cell envelope (cytoplasmic membrane and 
the cell wall (7)). ............................................................................................................................ 5 
 
Figure 2. Representative scheme of Gram-negative cell envelope (cytoplasmic membrane and 
the cell wall) (7). ............................................................................................................................ 6 
 
Figure 3. Representative scheme of fungal cell envelope (7). ...................................................... 7 
 
Figure 4.  Schematic model of biofilm development processes (95). ......................................... 10 
 
Figure 5. Schematic representation of three types of plant lectins: merolectins, hololectins and 
chimerolectins (64). .................................................................................................................... 14 
 
Figure 6. The X-ray structure of ConA (adapted from (70)). ....................................................... 15 
 
Figure 7. Exogenous lectin attached to the T cell targeting the altered glycoprotein present on 
tumor cell surface, promoting the lyses of the cell (65). ............................................................ 19 
 
Figure 8. Effect of lectins on bacteria and yeast planktonic growth (a – Pseudomonas 
aeruginosa; b - Klebsiella oxytoca; c – Staphylococcus aureus; d -  Staphylococcus epidermidis; e 
– Candida albicans; f – Candida tropicalis). *Statistically different from the control, 0 µg/mL (p 
< 0.05).......................................................................................................................................... 29 
 
Figure 9. Effect of lectins on bacteria and yeast early-stage adhesion (a – Pseudomonas 
aeruginosa; b - Klebsiella oxytoca; c – Staphylococcus aureus; d -  Staphylococcus epidermidis; e 
– Candida albicans; f – Candida tropicalis). *Statistically different from the control, 0 µg/mL (p 
< 0.05).......................................................................................................................................... 31 
 
Figure 10. Bacteria and yeast biofilm formation (quantification of biofilm mass) in the presence 
of lectins (a – Pseudomonas aeruginosa; b - Klebsiella oxytoca; c – Staphylococcus aureus; d -  
Staphylococcus epidermidis; e – Candida albicans; f – Candida tropicalis). *Statistically different 
from the control, 0 µg/mL (p < 0.05). ......................................................................................... 32 
 
Figure 11. Bacteria and yeast biofilm formation (determination of the number of viable biofilm-
entrapped cells) in the presence of lectins (a – Pseudomonas aeruginosa; b - Klebsiella oxytoca; 
c – Staphylococcus aureus; d -  Staphylococcus epidermidis; e – Candida albicans; f – Candida 
tropicalis). *Statistically different from the control, 0 µg/mL (p < 0.05). ................................... 34 
  
 
List of Tables 
xiii 
 
List of Tables  
 
Table 1. Microorganisms frequently associated with biofilms on medical devices ...................... 9 
 
Table 2. Common applications of plant lectins as tools in basic and medical sciences .............. 16 
 
Table 3. Summary table of results............................................................................................... 35 
  
 
 
 
 
List of Abbreviations  
xv 
 
List of Abbreviations  
 
Aal  Lectin from Araucaria angustifolia  
AHL  N-acyl homoserine lactone 
AIDS  Acquired Immune Deficiency Syndrome  
ATCC   American Type Culture Collection  
CECT  Spanish Type Culture Collection 
CFU    Colony forming unit 
ConA    Concanavalin A from Canavalia ensiformis 
ConBol   Lectin from Canavalia boliviana 
ConBr    Lectin from Canavalia brasiliensis  
ConM    Lectin from Canavalia maritima 
CV    Crystal violet 
DGL  Lectin from Dioclea grandiflora 
DVL  Lectin from Dioclea violacea 
EPS   Extracellular polymeric substance  
ER    Endoplasmic reticulum    
EuniSL  Lectin from Eugenia uniflora 
GlcNAc   N-acetil-D-glucosamine  
HHA    Lectin from Hippeastrum hybrid  
LTA    Lipoteichoic acids 
MIC  Minimum inhibitory concentration 
MOA    Lectin from Marasmium oreades 
MRSA    Methicillin-resistant Staphylococcus aureus 
OD   Optical density 
PBS   Phosphate buffered solution  
PHA    Lectin from Phaseolus vulgaris  
POL  Lectin from Pleurotus ostreatu 
PS    Polystyrene 
Psl   Polysaccharide synthesis locus  
PWM  Pokeweed mitogen 
RIPs    Ribosome inactivating proteins 
SBA    Soybean lectin
 
List of Abbreviations   
xvi 
 
SCID  Severe Combined Immunodeficiency 
SDA    Sabouraud Dextrose Agar 
SDB    Sabouraud Dextrose Broth 
SSTI    Skin and Soft tissue infections 
TFA  Lectin from Trigonella foenumgraecum 
TSA    Tryptic Soy Agar 
TSB    Tryptic Soy Broth 
WGA  Wheat germ agglutinin from Triticum vulgaris 
WTA    Wall teichoic acid 
 
  
 
 
 
 
  
 
 
 
Chapter 1 | Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
2 
 
1.1. Contextualization and objectives 
Today, bacterial and fungal infectious diseases are becoming hard to treat with 
conventional antimicrobial agents due to the development of resistance, being a serious 
health problem. This situation has promoted the search for new alternatives to treat infections 
and to control surface contamination.  
Natural products, mainly plant-derived, are the most searched and studied 
compounds. Lectins are one of the many compounds extracted from plants, being proteins 
without catalytic function or immunological characteristics that bind specifically to 
carbohydrates. One of the largest and most studied families of lectins is those derived from 
leguminous plants. 
Several lectins have been revealing to be able to inhibit bacterial and yeast pathogens, 
so, lectins may be important tools to control bacterial and fungal infectious diseases. 
Until now, plant-based research has almost exclusively focused on planktonic 
microorganism, while biofilm forms, that are more resistant to antimicrobial agents and, 
consequently, more difficult to control, stay largely unexplored. 
In this study, four plant lectins of Diocleinae subtribe (Canavalia ensiformis - ConA; 
Canavalia brasiliensis - ConBr; Canavalia maritima - ConM; Canavalia boliviana - ConBol) were 
screened for their effect on the growth, early-stage adhesion and subsequent biofilm 
formation of Staphylococcus epidermidis and Staphylococcus aureus (both gram positive 
bacteria), Pseudomonas aeruginosa and Klebsiella oxytoca (both gram negative bacteria) and 
for Candida albicans and Candida tropicalis. 
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1.2. Literature review 
It is common that microorganisms attach to wet surfaces and form structures named 
biofilms. Biofilms are structured communities of surface-associated microbial cells enclosed in 
a self-produced polymeric matrix, forming sessile populations (1).  
 Biofilms still a concern in a broad range of areas such as food, environmental and 
biomedical fields. They can play important roles in bioremediation and fermentation facilities, 
facilitating stable operations, but on the other hand they are very problematic, particularly in 
food and health sector (2) (3). Many persistent and chronic microbial infections are related 
with biofilms, and occur essentially in hospital settings by contamination of indwelling medical 
devices. Medical devices are contaminated by the flora from the patient or health care 
personnel after touching contaminated environmental surfaces (2) (4). Such infections are 
difficult to diagnose and treat with conventional approaches, because biofilms have intrinsic 
mechanisms responsible for their highly resistance to antimicrobial agents (5).  
The widespread use, and sometimes misuse, of antimicrobial agents leads to the 
development of microorganism resistance against conventional drugs (6). Microbial resistance 
is, nowadays, one of the biggest problems of public health. So, it is important to limit the 
spread of these microorganisms, limiting contamination of surfaces and medical devices, as 
well as finding appropriate antimicrobial agents for biofilm eradication (7).  
Currently, the search for new environmental friendly and more effective strategies to 
control both planktonic and sessile microorganisms is becoming a priority. The research 
communities and pharmaceutical industries are searching new alternatives based on natural 
products with antimicrobial activity and low toxicity (8-11).  
 
1.2.1. Microorganisms  
Bacterial and fungal infectious diseases are a serious health problem being the lead 
cause of premature deaths all over the world (12-14).  
Bacteria, such S. aureus, S. epidermidis, P. aeruginosa and K. oxytoca, and yeasts from 
Candida genus, are some of the microorganisms responsible for human infections and 
important agents of nosocomial infections.  
 
Staphylococcus epidermidis and Staphylococcus aureus 
S. epidermidis and S. aureus are both Gram-positive bacteria.  
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S. epidermidis is a commensal skin bacterium and an opportunistic pathogen, being 
frequently isolated from infected medical devices, such as catheters (15) (16). Its infections 
promote an increase of global morbidity and mortality, especially in neonates (4).   
S. aureus is the main etiological agent of numerous skin and soft tissue infections 
(SSTI). It remains the major human pathogen in hospital- and community- acquired infections 
causing diseases with high mortality rate (17). It is a common target for natural product drug 
screenings, because there has been observed an increase of antibiotics resistance, like 
methicillin-resistant S. aureus (MRSA) that presents a significant threat to public health (18) 
(19).  
 
Klebsiella oxytoca and Pseudomonas aeruginosa 
One of the most clinically important species of the genus Klebsiella is K. oxytoca. 
Klebsiellae are Gram-negative bacteria and opportunistic pathogens, being a frequent cause of 
severe diseases, such as urinary tract infections and pneumonia. Klebsiella infections are, 
essentially, associated with hospital care units (20) (21). 
 Another opportunistic Gram-negative bacterium, which is capable of causing fatal 
systemic diseases in humans, is P. aeruginosa. This pathogen infects patients, for example, 
when cutaneous barriers are breached and/or when immunologic system is compromised. 
Patients with respiratory diseases are commonly infected with P. aeruginosa and more than 90 
% of them eventually die. P. aeruginosa is responsible for innumerous diseases, like 
pneumonia, SSTI, endocarditis, septicemia, among others, being the fourth leading cause of 
nosocomial infection and the main cause of hospital-acquired pneumonia (22) (23).  
 
Candida albicans and Candida tropicalis 
Candida species are the most common fungi involved in invasive human diseases, 
especially in immunocompromised patients (24). 
C. albicans is generally considered to be an endogenous pathogen, but exogenous 
transmission (transmission from patient to patient by hands of health care personnel) is also 
verified (25). It is the main fungal pathogen agent found in humans, being responsible for both 
mucosal and deep tissue infections, such as infections of the skin, oral cavity, gastrointestinal 
tract, vagina and vascular system of humans (26) (27). Vaginal infections caused by C. albicans 
affect up to 75 % of women, at least, once in their life time (28). 
C. tropicalis is the second most frequent Candida species, being the main cause of 
bloodstream and urinary tract infections, especially in hospitalized patients (29). It is 
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considered highly virulent and an important cause of infections in patients with cancer, 
especially leukemia (25) (26) (29).  
 
1.2.2. Structure and components of the cell wall 
Cell wall acts as a permeability barrier, maintains the cell shape and mediates the 
initial interaction between microorganism and the environment (24). Moreover, it is 
characteristic of both bacteria and fungi and has a protective function but, on the other hand, 
it is vulnerable to some antimicrobial agents which have the capacity to disturb the processes 
by which the wall is synthesized. During cell growth and proliferation, cell wall is continuously 
undergoing biosynthesis and extension, because it is a dynamic structure. This feature makes 
bacteria and fungi susceptible to antimicrobial agents which disturb the biosynthesis of the cell 
wall (6).  
Cell wall structure of bacteria and fungi is different from each other, resulting in 
different susceptibilities to antimicrobial agents (6).  
 
1.2.2.1. Bacterial cell wall 
Gram-positive bacteria 
As demonstrated in Figure 1, the basic structure of Gram-positive bacteria wall is quite 
simple.  At least 50 % of wall mass is peptidoglycan, present in several layers. Peptidoglycan is 
organized in a cross-linked structure that provides a tough and fibrous fabric, giving shape and 
strength to the cell. This structure enables bacteria wall to resist a high internal osmotic 
pressure. Additionally, 30 to 40 % of the wall mass is due to an acidic polymer which is linked 
to peptidoglycan. This polymer is often a teichoic acid. There are two types of teichoic acids, 
namely wall teichoic acid (WTA) and lipoteichoic acid (LTA). Its acidic character guarantees that 
the cell surface is polar and carries a negative charge (6) (30).  
 
 
 
 
 
 
 
 
Figure 1. Representative scheme of Gram-positive cell envelope (cytoplasmic membrane and the cell wall (6)). 
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Teichuronic acid is synthesized, replacing teichoic acids, when phosphate supply to the 
cell is limited (6) (30).  
Moreover, 5 to 10 % of the wall mass is related with the proteins present on the 
structure. Cell wall also contains neutral sugars, such as mannose, arabinose, rhamnose and 
glucosamine, and acidic sugars, such as glucuronic acid and mannuronic acid, which are 
present on the cell wall as subunits of polysaccharides. These proteins and polysaccharides 
often occur in the outer layers of the wall, being almost responsible for antigenic properties of 
bacteria (6) (30).  
 
Gram-negative bacteria 
The Gram-negative cell wall is far more complex than Gram-positive cell wall, as 
observed in Figure 2. Peptidoglycan is no longer the major component of the cell wall, being 
present only one or two layers of peptidoglycan (representing 5 to 10 % of the wall mass) (6) 
(30). 
 
 
 
 
 
 
 
 
 
 
 
Just outside the cytoplasmic membrane, there is a layer called periplasmic space. This 
layer contains biochemical compounds, such enzymes, transport proteins, secreted materials 
and components of peptidoglycan. Immediately outside the periplasm, there is the 
peptidoglycan layer of the wall. It is much thinner than in Gram-positive bacteria, but still 
important to assure the wall strength (6) (31).  
After peptidoglycan layer, the cell wall contains three main components, such as 
lipoprotein, outer membrane and lipopolyssacharides (30).  
Figure 2. Representative scheme of Gram-negative cell envelope (cytoplasmic membrane and the cell wall) (6). 
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Lipoprotein is an important constituent of the outer membrane proteins. Only about 
one-third is linked to peptidoglycan, and the remaining, despite of being unattached, forms 
part of the membrane (6) (30) (31).   
The outer membrane is composed by various compounds. It is basically a lipid bilayer 
with protein components. Lipopolysaccharide, phospholipids, fatty acids and proteins are the 
main constituents of this layer. The structure of lipopolysaccharide is complex and can vary 
from one bacterial strain to another. Lipopolysaccharides are exclusively on the outer surface 
of the outer membrane (6) (30) (32).  
 
1.2.2.2. Fungal cell wall 
Polysaccharides are the main component of fungal cell wall representing 
approximately 80 % of the cell wall dry weight (Figure 3). Proteins, lipids and various inorganic 
salts compose the others 20 % (33). The main polysaccharides found in diverse fungi cell wall 
are various forms of glucans and 
chitin, such as branched polymers of 
glucose containing β-1,3 and β-1,6 
linkages (β-glucans), unbranched 
polymers of N-acetil-D-glucosamine 
(GlcNAc) containing β-1,4 bonds 
(chitin) and polymers of mannose covalently associated with proteins (24) (33) (34).  
Chitin and β-glucans (microfibrillar polymers) form the external skeleton representing 
the structural components of the cell wall. The skeleton provides strength to the cell (24) (33).   
Although yeast cell wall composition is similar to the filamentous forms, hyphal cells 
contain at least three times more chitin than yeast cells (24) (33).  
Proteins of the fungal cell wall are involved in permeability control, in recognition of 
other fungi, regulation of several processes and interaction with hosts (33). 
 
1.2.3. Cell adhesion as virulence factor 
Attachment of microorganisms, like bacteria, to tissues is the first step in the 
establishment of infection (18). Microorganism ability to adhere and consequently form a 
biofilm, which can cause an infection, is one of the major virulence factors (35).  
Adhesion is a distinct process, but essential for biofilm development, that can be 
divided into two stages, namely the primary adhesion (docking stage) and the secondary 
adhesion (locking phase) (36).  
Figure 3. Representative scheme of fungal cell envelope (6).  
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Primary adhesion between bacteria/fungi and abiotic surfaces is usually mediated by 
nonspecific interactions, and between microorganism and living or devitalized tissues is 
mediated through specific molecular mechanisms (36).  
This stage is reversible and dependent on the interaction between the microorganism 
cell surface and the conditioned surface. At an early stage, the organism has to achieve a 
critical proximity to the surface (generally < 1 nm). Then, adhesion depends on the sum of 
attractive or repulsive forces existent between the two surfaces, such as electrostatic and 
hydrophobic interactions, steric hindrance, Van der Waals forces, temperature, and 
hydrodynamic forces, among others. Electrostatic interactions are, generally, repulsive forces, 
because most bacteria and inert surfaces are negatively charged. Hydrophobic interactions are 
frequently the strongest of all long-range non-covalent forces, playing an important role in 
adhesion and consequently in microbial infections (3) (35) (36). The hydrophobicity of the 
conditioned surface can vary a lot, because it is dependent on the molecules in the 
conditioning film (15) (36).  
Repulsion existent between two surfaces can be override by specific molecular 
interactions mediated by adhesins present on extracellular filamentous appendages (for 
example, pili and flagella) (3) (36). Pili are responsible to make cells more adhesive, so cells 
with these filamentous appendages adhere strongly to other cells or inorganic surfaces. 
Probably pili are capable to overcome the initial electrostatic repulsion barrier existent, being 
important to surface colonization (3).  
Molecular mediated binding between specific adhesins and the surface is employed in 
the second stage of adhesion. Microorganisms consolidate the adhesion process producing 
exopolysaccharides. At the end, adhesion becomes irreversible being the microorganism firmly 
attached to the surface, without any physical or chemical interference (37) (38).  
 
1.2.4. Biofilms 
A biofilm is a well organized cooperating community of surface-associated microbial 
cells enclosed in a self-produced polymeric matrix (36) (37).  
In response to environmental changes, microorganisms switch between planktonic 
growth and sessile form of life (2). Biofilm-associated microorganisms have a different 
behavior from planktonic organisms. They have reduced growth rates and ability to resist to 
antimicrobial treatments and host defenses, being a significant factor in microorganism 
virulence (4) (38) (39).   
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About 60 % of human infections results from biofilm formation on human mucosa (40). 
Biofilm are able to develop into implants and medical devices, such as catheters, cardiac 
valves, artificial joints, plates and screws, causing nosocomial infections (Table 1). These 
biofilms present in medical devices are usually a source of recurrent infections, which are 
notoriously more difficult to eradicate (2) (41). So, biofilm associated infections account for 
high morbidity and mortality rates (8) (42).  
  
 
 
 
 
 
 
 
 
Depending on the device and its duration of action, biofilms can be formed by single or 
multiple species of microorganisms. For example, urinary catheter biofilm can be composed of 
single species at the beginning, but longer exposures lead to multispecies biofilms (38) (43). 
These biofilms on indwelling medical devices can include either yeast, Gram-positive or Gram-
negative bacteria (38).  
It is obviously that microorganisms have benefits from the biofilm mode of growth, 
such as a protective environment against harmful conditions in the host, ability to survive a 
nutrient limitation, osmotic stress, pH changes, anoxia, mechanical stress and exposure to 
antibiotics (2).  
 
 
 
Microorganism Has been isolated from biofilms on 
Candida albicans Artificial voice prosthesis 
Central venous catheter 
Intrauterine device 
Coagulase-negative staphylococci Artificial hip prosthesis 
Artificial voice prosthesis 
Central venous catheter 
Intrauterine device 
Prosthetic heart valve 
Urinary catheter  
Klebsiella pneumoniae Central venous catheter 
Urinary catheter 
 
Pseudomonas aeruginosa Artificial hip prosthesis 
Central venous catheter 
Urinary catheter  
 
Staphylococcus aureus Artificial hip prosthesis 
Central venous catheter 
Intrauterine device 
Prosthetic heart valve 
Table 1. Microorganisms frequently associated with biofilms on medical devices (adapted from (37)) 
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1.2.4.1. Biofilm development  
Biofilm formation process may be divided into initial attachment, microcolony 
formation, maturation and dispersion, as shown in Figure 4 (2).  
 
On the second stage of adhesion, microorganisms are firmly attached to the surface, 
producing extracellular polymeric substance (EPS). Adhesion is closely followed by cell division 
and proliferation, raising microcolonies (1). This stage is a crucial step for biofilm development 
being the foundation upon which the mature biofilm will be built (36).  
After establishment of microcolonies, the maturation process begins (2). The density 
and complexity of biofilm increase. Surface-adhered microorganisms actively replicate and 
extracellular components are generated through interaction between cells and molecules in 
immediate environment, raising glycocalyx (36).  
Depending on environmental conditions, biofilms, for example from P. aeruginosa, can 
take a flat or mushroom-shaped structure (Figure 4). A flat structure is formed by means of 
twitching motility bacteria spread on the surface forming a confluent mat of cells. On the other 
hand, the migration of motile subpopulations of biofilm to the surface of a non-motile 
subpopulation (stalk) originates the caps, forming the mushroom-shaped structure (2). The 
growth potential and shape of a biofilm is dependent of the availability of nutrients, the 
perfusion of those nutrients to the cells within the biofim, the removal of waste, the internal 
pH, oxygen perfusion, osmolarity and carbon source (1) (36).  Studies revealed that, when 
glucose is used as a carbon source, P. aeruginosa PAO1 forms biofilms with a mushroom-
shaped structure, but when citrate, benzoate or casamino acids are used P. aeruginosa forms 
flat biofilms (44).  
Fungi like C. albicans have the ability to grow with three different morphologies, such 
as yeast, pseudohyphae and hyphae. Hyphal growth is believed to be one of the most 
Figure 4.  Schematic model of biofilm development processes (91). 
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important virulence factors (27) (28). Commonly, Candida species biofilms consist of two 
distinct layers, a thin, basal dense region of yeast cells, and an overlying thicker, but more 
open, hyphal layer, which raise a mushroom-shaped structure (41) (45). Dimorphism is not 
absolutely necessary for biofilm formation, but might be essential for the development of a 
spatially organized structure (41).  
The last stage of biofilm development is dispersion (2). When a biofilm reaches a 
critical mass, a dynamic equilibrium is reached with the detachment of a subpopulation of 
biofilm cells (outermost layer of growth) which revert to a planktonic lifestyle. These 
organisms are free to escape from mature biofilm and colonize other surfaces (2) (36).  
 
Cell to cell signaling, known as quorum sensing, has been demonstrated to play a role 
in cell attachment and detachment from biofilms, influencing biofilm maturation (37) (43).  
Intracellular communication between microorganisms is usually carried out by 
bacteria/fungi products that are able to diffuse away from one cell and enter into another cell 
(43). Extracellular accumulation of signaling molecules synchronize expression of a set of genes 
which allow monitoring a factor such as cell population density (2).  
Beyond preventing overpopulation, cell to cell signaling may alter distribution of 
microorganisms in the biofilm, alter protein expression and introduce new genetic in 
neighborhood cells, and incorporate microorganisms in biofilm (43) (45).  
Studies revealed that farnesol acts as a quorum-sensing molecule inhibiting 
filamentation in C. albicans. Biofilm formation was almost completely inhibited when C. 
albicans cells was preincubated with high concentrations of farnesol. Moreover, supernatants 
recovered from mature biofilms inhibited filamentation of planktonic C. albicans, indicating 
that a morphogenetic autoregulatory compound (probably farnesol) is produced in biofilms 
(46).   
On Gram-negative bacteria, such as P. aeruginosa, the best studied quorum sensing 
system is the LuxR-LuxI system, which uses an N-acyl homoserine lactone (AHL) as quorum 
sensing signal (47). Hentzer and colleagues (48) reported that a halogenated furanone 
compound (derivative of the secondary metabolites produced by Delisea pulchra) was able to 
interfere with AHL in P. aeruginosa. This interference affected the architecture of the biofilm 
and enhanced the process of bacterial detachment, leading to a loss of bacterial biomass from 
the substratum.   
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1.2.4.2. Biofilm resistance to antimicrobial agents 
Biofilms are commonly highly resistant to antimicrobial agents (2). Several studies 
revealed that bacterial cells in a biofilm can become 10-1000 times more resistant to 
antibiotics than corresponding planktonic growing bacteria (1).   
However, the mechanisms responsible for the resistance of biofilms to antimicrobial 
agents are not fully understood (41). Several mechanisms were proposed to explain the 
resistance of biofilms, including restricted penetration of drugs through biofilm matrix; the 
slow growth rates of biofilm; the appearance of resistant strains and phenotypic variants 
within biofilm populations, and expression of biofilm-specific genes (1) (2) (41). 
 
Restricted penetration  
Microorganisms in biofilms tend to be within the EPS matrix rather than on its surface. 
So, they are less accessible to antimicrobial agents. Thus, poor penetration of antimicrobial 
agents is suggested as one of the factors accounting for the resistance of biofilms (2) (41).  
A reaction of the compound or its adsorption by the components of the biofilm matrix, 
result in slow diffusion rates and delayed penetration of antimicrobial agents within the 
biofilm. So, higher concentrations of antimicrobial agents are needed to kill biofilm cells 
regarding their planktonic counterparts (1) (2) (41). 
For instance, P. aeruginosa biofilm formed on dialysis membranes delayed piperacillin 
diffusion suggesting that the biofilm matrix acts like a diffusion barrier to that antibiotic (2).  
 
Slow growth rate 
Biofilm cells grow slowly, mainly in mature biofilms, because of the limited availability 
of nutrients and the anaerobic conditions, particularly at the base of the biofilm (2) (36) (41). 
For example, beta-lactams and imipenem show low activity against mature biofilms, but they 
become more effective with younger biofilms (2).  It is believed that oxygen limitations slow 
down microbial growth as it restricts the metabolic activity of the cells. Slow growth rate, 
oxygen limitation and low metabolic activity may be responsible for the antimicrobial 
resistance in biofilms. A slow growth rate is frequently accompanied by modifications in cell 
surface composition that could, in turn, affect the cell susceptibility to antimicrobial agents (2) 
(36) (41). 
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Persisters and phenotypic variants 
Brooun and colleagues (49) observed that most of the P. aeruginosa biofilm cells were 
killed by a low concentration of antibiotics, but a subpopulation of cells survived even after a 
further antibiotic treatment with higher concentrations. These cells were called ‘persisters’ 
and it is thought that their programmed cell dead is disable.  It is believed that physiological 
adaptive changes in persisters cells are responsible for the extraordinary survival ability of the 
biofilms (1) (2).   
When microorganisms adhere to a surface and develop a biofilm they express an 
altered phenotype (1) (2) (41). Some researchers (49) (50) have started to identify genes that 
are repressed or activated in biofilms relatively to planktonic cells, with special interest in 
genes that may contribute to antimicrobial resistance. A recent study (51) demonstrates that 
genes encoding the two types of efflux pump present in C. albicans are upregulated during 
biofilm formation and development.  
In conclusion, antimicrobial resistance in bacterial/fungal biofilms is a complex process 
that cannot be explained by a single molecular mechanism (41). 
 
1.2.5. Natural antimicrobial agents 
Natural products have been used since ancient times (52). For instances, penicillin was 
discovered in 1938, but its entirely development took place in twentieth century. With the 
discovery of penicillin, a new era began, being natural products replaced by synthetic or semi-
synthetic substances. Antibiotics had an enormous success in controlling acute bacterial 
infections (6) (39) (52).  However, bacteria, as well as fungal pathogens, have developed 
antimicrobial resistance against conventional antimicrobial agents due to widespread and 
indiscriminate use of these drugs (6).  
The development of microbial drug resistance and drug-related toxicity has promoted 
the search for new alternatives, as natural drugs, to control, mainly, healthcare-associated 
infections (8-11). So, currently, there has been a widespread interest in the study of plant-
derived compounds as alternatives for microbial control (11) (40) (53). 
Natural compounds are generally accepted because of the perception that they are 
safe (as they have been used in folk medicine, since many years ago, for the prevention and 
treatment of infections and diseases) (40). Many components can be extracted from plants, 
such as lectins, extracts, essential oils and secondary metabolites (10) (54)  (52). 
 
 
 
Introduction 
14 
 
1.2.5.1. Lectins 
Lectins are proteins or glycoproteins with, at least, one carbohydrate or derivate 
binding site without catalytic function (non-enzimatic) or immunological characteristics (non-
immune) (55-58). They have the capacity to bind, reversibly and with high specificity, to mono- 
and oligosaccharides without suffer any chemical modification. This distinguishes lectins from 
other enzymes and carbohydrate binding proteins, and makes them important tools for 
biotechnological and biomedical applications (56) (59-61).  
Peumans and Van Damme (62) distinguished lectins in three major types based on 
their structure, namely “merolectins”, “hololectins” and “chimerolectins”. Merolectins (Figure 
5) are small, single polypetide proteins, which are built exclusively of a single carbohydrate-
binding domain. Because of its 
monovalent nature, they are 
incapable of precipitating 
glycoconjugates or agglutinating 
cells. Hololectins (Figure 5) have 
similar structural pattern as 
merolectins, but contain two or 
more carbohydrate-binding 
domains, which are very 
homologous. The majority of all 
known plant lectins are 
comprised in this group, because they have multiple binding sites, being capable of 
agglutinating cells or precipitating glycoconjugates (62) (63). Chimerolectins (Figure 5) are a 
group of fusion proteins which possess a carbohydrate-binding domain and an unrelated 
domain with another biological activity (for example catalytic activity) that acts independently 
of carbohydrate-binding domain. Chimerolectins can behave as merolectins or hololectins, 
depending of the number of sugar-binding sites (62) (63). For example, type 2 ribosome-
inactivating proteins (RIPs) with two carbohydrate-binding sites on their B chain (e.g. ricin) 
agglutinate cells, whereas class I plant chitinases with a single chitin-binding domain do not 
(62) (64).  
The first lectin discovered was ricin, a very toxic protein from Ricinus communis. It was 
extracted by Stillmark in 1888 (65). The first lectin isolated, sequenced and with tree-
dimensional structure determined by x-ray crystallography, was ConA from Canavalia 
ensiformis (Figure 6). ConA is the best characterized plant lectin, with a high number of studies 
Figure 5. Schematic representation of three types of plant lectins: 
merolectins, hololectins and chimerolectins (62). 
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(biochemical, biophysical and structural) (65) (66). ConA is a Diocleinae (Leguminosae) lectin 
and all Diocleinae lectins studied have many 
chemical, physic-chemical and structural 
properties in common. They share the same 
monosaccharide specificity for D-glucose and D-
mannose and, despite their high similarity, they 
have distinct biological activities (9) (67) (68). 
The different biological activities are mainly due 
to changes in three parameters, such as binding 
specificity to complex carbohydrates, pH-
dependent oligomerization state and the 
relative orientation of carbohydrate-binding sites. These differences in the described 
parameters among the lectins may result from specific amino acid replacements at key 
positions along their primary structures (66). 
Lectins may interact with carbohydrates through hydrogen bounds, Van der Waals 
forces, metal coordination and hydrophobic interactions. Essentially, hydroxyl groups on sugar 
molecules can serve both as a donor and an acceptor to cooperate in hydrogen bonds (69-71).  
Most plant lectins studied are biosynthesized via the secretory pathway. Lectins are 
synthesized at ribosomes attached to the endoplasmic reticulum (ER). Then, lectins enter the 
lumen of the ER and are further transported through the Golgi apparatus (where lectins are 
modified by the glycosylational process), ending up in the vacuole (65) (72).  
 
Lectin sources 
Lectins are widely distributed in nature as they can be found in all kingdoms of life, 
ranging from animals, microorganisms (bacteria, yeasts and viruses) and plants (55) (58) (73).  
Plants were the first discovered source of lectins, and remain the most frequently used 
(57). 
Plant lectins can be framed in, at least, seven distinct families. The mainly four families 
of structurally and evolutionary related proteins are the legume lectins, the type 2 RIPs, the 
chitin-binding lectins, and the monocot mannose-binding lectins (74) (75). Legume lectins are 
the largest and most studied family of plant lectins. Some of the best known legume lectins are 
jackbean (ConA), soybean (SBA) and phytohemagglutinin (PHA) (76).  
Additionally, smaller families (Cucurbitaceae phloem lectins, amaranthins and jacalin-
related lectins) have also been characterized (74) (75).   
Figure 6. The X-ray structure of ConA (adapted from 
(68)). 
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Different families of plants, as well as different tissues of the same plant, can contain 
different lectins with different bioactivities and different carbohydrate-binding specificities 
(57) (77).  
The richest sources of most lectins are the storage organs of plants, especially seeds. 
But also roots (Urtica, Calystegia), tubers or bulbs (Allium, Tulipa), bark (Sophora, Robinia) or 
leaves (Aloe, Lactuca) can contain significant amounts of lectins. The amount of lectin can be 
different from one plant species to other (65).  
 
Biological activities and applications of lectins 
Monosaccharides, such as mannose, galactose, N-acetylgalactosamine, N-
acetylglucosamine, fucose and N-acetylneuraminic acid, are typical constituents of surfaces of 
eukaryotic cells. Almost all lectins have high specificity for the sugars describes above, being 
this fact relevant for biological activities of lectins. The binding of lectins is dynamic and 
reversible. The association constant of lectin-monosaccharide interactions is relative low (in 
millimolar range) and lower than lectin-oligosaccharide interactions, however it is often highly 
selective. This is due to the fact that lectins exhibit an exquisite specificity for di-, tri-, and 
tetrasaccharides (76).  
Lectins ability to bind carbohydrates with considerable specificity makes them valuable 
tools in scientific research, particularly in clinical, biochemical and biotechnology studies (76) 
(78). Some examples of common applications of plant lectins as tools in basic and medical 
sciences are demonstrated in Table 2. 
Table 2. Common applications of plant lectins as tools in basic and medical sciences (adapted from (65)) 
Biochemistry 
Detection of defined carbohydrate epitopes of glycoconjugates in blots or on thin-layer chromatography plates 
Purification of lectin-reactive glycoconjugates by affinity chromatography 
Glycan characterization by serial lectin affinity chromatography 
Glycome analysis (glycomics) 
Quantification of lectin-reactive glycoconjugates in enzyme-linked lectin-binding assays (ELLA) 
Quantification of activities of glycosyltransferases/glycosidases by lectin-based detection of products of enzymatic 
reaction 
Cell biology 
Characterization of cell surface presentation of glycoconjugates and their preceding intracellular assembly and 
routing in normal and genetically engineered cells 
Analysis of mechanisms involved in correct glycosylation by lectin-resistant cell variants 
Fractionation of cell populations 
Modulation of proliferation and activation status of cells 
Model substratum for study of cell aggregation and adhesion 
Medicine 
Detection of disease-related alterations of glycan synthesis 
Blood group typing and definition of secretor status 
Quantification of aberrations of cell surface glycan presentation, e.g. in malignancy 
Cell marker for diagnostic purposes incl. infectious agents (viruses, bacteria, fungi, parasites) 
Mitogenic stimulation of lymphocytes 
Purging of bone marrow for transplantation 
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 Blood typing 
Lectins are frequently used for applications based on agglutination or precipitation 
reaction (76). ConA is capable of agglutinates erythrocytes and yeasts, as consequence of 
lectin interaction with carbohydrates on the surface of the cells. Lectins with ability to 
agglutinate erythrocytes are named as hemagglutinins (79).  
Most legume lectins have hemagglutinating activity and most of them also exhibit 
blood type specificity, so they can recognize the difference in blood group antigens having the 
carbohydrate epitopes (ABO, Le, Ii, T, Tn, Forssman antigens, etc.). Studies revealed that 
extracts of the asparagus pea (Lotus tetragonolobus) only agglutinated blood type O 
erythrocytes, whereas crude extracts of the lima bean (Phaseolus limensis) agglutinated only 
blood type A erythrocytes. The lectin from Dolichos biflorus is used to distinguish between A1 
and A2 blood subgroups (63) (76) (79).    
Hemagglutinins which exhibit blood type specificity played a key role in early 
investigations on the structural basis of the specificity of the antigens associated with the ABO 
blood group system (79).  
 
 Antibacterial and antifungal activity 
Owing to the physiological functions of plant lectins in nature (plant’s defense), 
antibacterial and antifungal activity of lectins has been intensively discussed (62). Interactions 
between lectins and human pathogenic microorganisms were reported since many years ago 
(58). Lectins are extensively used in microbiology and parasitology domain for identification of 
the agent structures and with protective effect against infection (66).  
Recently, several studies were carried out to verify whether lectins have some 
antibacterial and/or antifungal activity. Cavalcante and colleagues (80) verify that 
Staphylococcus mutans growth was affected by ConBol, ConBr and ConM lectins. Oliveira and 
colleagues (58) demonstrated that a lectin from Eugenia uniflora (EuniSL) strongly inhibited 
the growth of S. aureus, P. aeruginosa and Klebsiella sp. and moderately inhibited the growth 
of Bacillus subtilis, Streptococcus sp. and Escherichia coli. Santi-Gadelha and colleagues (77) 
used a lectin from Araucaria angustifolia (Aal) against Gram-positive and Gram-negative 
bacteria concluding that this lectin had stronger antimicrobial activity. They observed, through 
electron microscopy, the presence of pores and severe disruption of the Gram-positive 
bacteria membrane and substantial bubbling in Gram-negative cell wall, besides some 
destroyed bacteria.  
 Lectins from the seeds of Phaseolus vulgaris and Pisum sativum (81), from the 
mushroom Astragalus mongholicus (82), and from the pepper seed Capsicum frutescens (83), 
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have been reported to have antifungal activity.  Antifungal properties have also been found 
from the pepper seeds Capsicum annuum by Kuku and colleagues (83), and from a chitin-
binding lectin from Talisia esculenta (84). This latter lectin had antifungal activity against 
Fusarium oxysporum, Saccharomyces cerevisiae, etc.  
Charungchitrak and colleagues (57) demonstrated that a lectin from the seeds of 
Archidendron jiringa had antifungal activity against, for example, Exserohilum turcicum and 
Colletotrichum cassiicola, and antibacterial activity against Gram-positive and Gram-negative 
bacteria, such as P. aeruginosa and S. aureus. These results indicated that some lectins are 
able to inhibit both bacteria and yeasts pathogens (57).  
 
 Mitogenic stimulation 
The first lectin found with mitogenic activity was PHA (lectin from Phaseolus vulgaris), 
but nowadays there are several lectins with this capacity. A mitogenic lectin possesses the 
ability to stimulate lymphocytes to undergo mitosis. The activation of lymphocytes occurs as a 
result of binding of lectins to cell surface sugars (79) (85).   
Lectins such as PHA and ConA are able to stimulate T lymphocites (T cells), while 
pokeweed mitogen (PWM) is able to stimulate both T and B cells. This stimulation by lectins 
provides an easy and simple means to assess the immunocompetence of patients which suffer 
from a diversity of diseases, including AIDS (Acquired Immune Deficiency Syndrome), and to 
monitor the effects of various immunosuppressive and immunotherapeutic manipulations 
(76). 
 
 Antiproliferative activity and cancer diagnosis 
Lectins have been shown to be of great interest since they have been reported as 
potential anticancer agents. They have been tested as adjuvants in tumor treatment and in 
diagnosis (66).   
For example, lectins like Agaricus bisporus, Tricholoma mongolicum and Volvariella 
volvacea have antiproliferative and antitumor action. Wang and colleagues (86) demonstrated 
that lectin from Pleurotus ostreatus (POL) when administrated in mice promotes a dramatic 
shrinkage of sarcoma S-180 and hepatoma H-22 cells, having a potent antitumor activity. A 
similar situation was observed when three cancer cell lines (HeLa, L929 and EATC) were 
treated with ConA and PHA-P lectins. These lectins inhibited cell proliferation and caused 
damages on cell lines used, being the effect of PHA-P stronger than ConA.  Cells showed 
morphological changes (damages), such as dilatation of mitochondria, cytoplasmic 
vacuolation, rounded cells and cell aggregation (87).   
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Development of cancer cells seems to be associated with changes in cell surface sugars 
which lead to the assumption that high susceptibility to agglutination by lectins was a property 
shared by malignant cells. Wheat germ agglutinin (WGA) and ConA have the ability to 
selectively agglutinate neoplastic cells (79).  Because malignant cells display altered surface 
glycoproteins, exogenous lectins tagged with the killer T cells can promote the lyses of tumor 
cells, controlling tumor (Figure 7). Also, lectins present on the surface of malignant cells are 
able to binding exogeneous sugars which contain molecules and are capable of internalizing 
them by endocytosis, having a potential use in cancer treatment strategies (63).  
 
 
 
 
 
 
 
 
 
 Bone marrow transplantation 
Some lectins have been used in organ transplantation applications. Selective 
agglutination by SBA allows separation of B and T mouse splenocytes (bone marrow).  Since 
1981 SBA lectin is used for purging human bone marrow for transplantation. It is employed 
frequently for transplantations into children born with severe combined immune deficiency 
(SCIDs or “bubble children” – they are highly susceptible to microbial infections). About 75 % 
of the hundreds of children transplanted after SBA purging of bone marrow have been cured 
and lead a normal life. SBA-purged bone marrow was also used experimentally for treatment 
of end stage leukemia patients, as an alternative to other techniques for T cell depletion, such 
as monoclonal antibodies (76) (85).  
Figure 7. Exogenous lectin attached to the T cell targeting the altered glycoprotein present 
on tumor cell surface, promoting the lyses of the cell (63).  
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2.1. Lectins origin 
The lectins Canavalia ensiformis - ConA; Canavalia brasiliensis - ConBr; Canavalia 
maritima – ConM and Canavalia boliviana - ConBol were gently provided by Professor Benildo 
Cavada from BioMol-Lab (Laboratory of Biologically Actives Molecules, Department of 
Biochemistry and Molecular Biology, Federal University of Ceará - Brazil).  
 
2.2. Lectins stock solution 
Phosphate buffered solution (PBS) was prepared in sterilized water being added 8 g/L 
of sodium chloride (NaCl), 0.2 g/L of potassium chloride (KCl), 0.3 g/L of potassium dihydrogen 
phosphate (KH2PO4) and 1.15 g/L of disodium phosphate (Na2HPO4). The pH was adjusted to 
7.0. Before being used, this solution was autoclaved at 121 ˚C for 15 minutes and reserved at 
room temperature.  
The Diocleinae lectins were solubilised in PBS previously prepared, at 37 °C and 120 
rpm for 3 h, in order to obtain stock solutions with a concentration of 1 mg/mL. After that, the 
solutions were filtered through a 0.22 µm cellulose filter and preserved at 4 °C.  
 
Immediately prior to experiments, the lectin stock solution was diluted in Tryptic Soy 
Broth (TSB; Liofilchem) for bacteria, and in Sabouraud Dextrose broth (SDB; Liofilchem) for 
yeasts, to obtain the concentrations of 62.5, 125, 250 and 500 µg/mL of lectin. Then, bacteria 
and yeasts suspensions (after its concentrations has been adjusted) were added to the diluted 
solutions of lectins, obtaining the final concentrations of 31.2, 62.5, 125 and 250 µg/mL of 
lectins used in experiments.  
 
2.3. Microorganisms and culture conditions 
The microorganisms used in the experiments are all reference strains from American 
Type Culture Collection (ATCC) and Spanish Type Culture Collection (CECT). This included two 
Gram-positive bacteria (Staphylococcus epidermidis CECT231 and Staphylococcus aureus 
ATCC), two Gram-negative bacteria (Klebsiella oxytoca ATCC13182 and Pseudomonas 
aeruginosa ATCC10145), and two yeasts (Candida albicans ATCC1472 and Candida tropicalis 
ATCC750). 
 Bacteria were preserved at – 80 ˚C in TSB supplemented with 20 % glycerol. Yeasts 
were preserved at – 80 ˚C in SDB supplemented with 10 % glycerol. 
Prior to each experiment, bacteria and fungi cells were grown, respectively, on Tryptic 
Soy Agar (TSA; Merck) and on Sabouraud Dextrose Agar (SDA; Liofilchem) plates for 24 h, at 37 
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˚C. These media were previously prepared and autoclaved at 121 ˚C for 15 minutes and 
reserved at room temperature.  
 
After 24 h of growth on solid media, an isolated colony of each microorganism was 
removed and used to inoculate 20 mL of TSB or SDB, and incubated for 18 h, at 37 °C, under 
constant agitation of 120 rpm.  
Prior to use, the bacteria and yeasts suspensions were adjusted to a final 
concentration of 2 x 108 cells/mL (for early adhesion characterization) and 1 x 106 cells/mL (for 
planktonic and biofilm growth tests). Bacterial suspensions were adjusted through the 
measurement of the optical density (OD) at 640 nm and calibration curves, previously 
determined for each bacterium. The yeasts inocula were adjusted using a Neubauer chamber. 
 
2.4. Lectin antimicrobial activity  
All bacteria and yeast suspensions were adjusted to 1 x 106 cells/mL, and then 100 µL 
of each suspension were transferred to a 96-well tissue culture plates (Orange Scientific), 
previously prepared with 100 µL of TSB or SDB supplemented with a dose of each lectin 
(described on section 2.2). These plates were incubated during 24 h at 37 °C and 120 rpm. 
 Microbial growth was determined through measurement of optical density at 640 nm 
of the liquid content of each well using a microtiter plate reader, being the bacteria and yeast 
planktonic growth results presented as OD640 nm. 
Negative control, wells contained culture medium only, was also performed in order to 
determine whether the tested medium interfere with the measurement of planktonic growth.  
 
2.5. Lectin effect on early-stage adhesion 
To verify the effect of lectins on bacteria and yeast early-stage adhesion, the cells were 
put in contact with a range of concentrations of all lectins, during 2 h at 37 °C and 120 rpm. 
Each bacteria and yeast suspensions were previously adjusted to 2 x 108 cells/mL. Then, 500 µL 
of each cell suspension was transferred to a 24-well tissue culture plates (Orange Scientific), 
containing 500 µL of TSB or SDB per well, supplemented with a dose of each lectin (described 
on section 2.2). 
After 2 h of contact, the content of each well was removed, the adhered cells were 
washed twice with sterilized water, being the biomass quantified by crystal violet (CV) staining, 
according to Stepanovic and colleagues (88). For that, the plates containing the adhered cells 
were left to air dry for 30 min, and 1 mL of 98 % methanol were transferred to each well in 
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order to fix the remaining attached cells, for 15 min. Afterwards, the plates were emptied and 
left to air dry. The fixed cells were stained with 1 mL of CV (Gram’s staining; Merck) per well, 
for 5 min. After this staining step, plates were washed with running tap water, air dried, and 
filled with 1 mL of 33 % (v/v) of acetic acid (Merck) in order to resolubilize the CV bound to the 
adherent cells. After that 200 µL of each well was transferred to a 96-well tissue culture plates 
and the quantitative analysis of adhered cells was performed through the measurement of 
optical density at 570 nm of each well using a microtiter plate reader, being the results 
presented as OD570nm. Negative control, wells contained culture medium only, was also 
performed in order to determine whether the tested media and the plate material could 
adsorb CV and interfere with the adhered cells quantification. 
 
2.6. Biofilm prevention 
To assess whether the presence of the lectins could interfere with the establishment of 
biofilms by bacteria and yeasts on polystyrene (PS) surfaces, biofilms (24 h) were allowed to 
form in the presence of a range of concentrations of all lectins. Biofilms were developed using 
the microtiter plate test developed by Stepanovic and colleagues (88).  Briefly, 100 μL  of each 
bacteria and fungi suspensions, previously adjusted to 1 x 106 cells/mL, were transferred to 
each well of a 96-well tissue culture plates (Orange Scientific) containing 100 μL of TSB or SDB 
per well supplemented with a dose of each lectin (described on section 2.2).  
After 24 h of biofilm growth, the content of each well was removed; biofilms were 
washed twice with sterilized water and reserved for further characterization. 
 
2.6.1. Biofilm biomass quantification 
The biomass of the biofilms was quantified by a staining method, as described for early 
adhesion. For quantification of the biofilm mass, the quantities of methanol, CV and acetic acid 
were 200 μL per well. After resolubilize the CV bound to the adherent biofilm, the quantitative 
analysis of biofilm mass was performed through the measurement of optical density at 570 nm 
of each well using a microtiter plate reader, being the biofilm mass presented as OD570nm. 
Negative control, wells contained culture medium only, was also performed in order to 
determine whether the tested media and the plate material could adsorb CV and interfere 
with the biofilm biomass quantification. 
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2.6.2. Biofilm viable cells enumeration 
In order to determine the number of viable biofilm-entrapped cells, biofilm 
suspensions were prepared.  
 For the bacterial biofilms, 200 µL of sterilized water were added to each well, being 
the biofilms detached by ultrasonic bath in a Sonicor SC-52 (Sonicor Instruments) operating at 
50 kHz, during 6 min. The yeasts biofilm cells suspensions were obtained by completely 
scraping the adhered biomass from the wells, through the use of a yellow tip, into 200 µL of 
sterilized water. Afterwards, the biofilm suspensions of each 2 wells per condition were 
collected and gently vortexed for 1 min to disrupt possible cell aggregates (these parameters 
were previously optimized in order to promote the complete removal of all the biofilm-
attached cells without lysis).  
Biofilm suspensions were then serially diluted, plated on TSA (bacterial suspensions) or 
on SDA (yeasts suspensions), and incubated at 37 °C in an aerobic incubator for 24 h. The 
number of colony forming units (CFU) was enumerated, being the biofilm cell numbers 
presented as log10 (CFU/cm
2). 
 
2.7. Statistical analysis 
Statistical analyses were performed by PASW Statistics. The method used was one-way 
ANOVA with Tukey post hoc test. Data were obtained in triplicates from, at least, three 
separate experiments. The results were presented as mean ± standard deviation (SD). A P-
value 0.05 was considered indicative of statistical significance.  
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3.1. Bacterial and yeast planktonic growth 
After 24 h in contact with lectins, bacteria and yeast growth was determined through 
measurement of optical density at 640 nm. The effect of lectins on microbial planktonic 
growth is shown in Figure 8.  
For P. aeruginosa (Figure 8a) and K. oxytoca (Figure 8b), both Gram-negative bacteria, 
the higher concentration of the all lectins, with the exception of ConBol, showed inhibitory 
activity (p<0.05). 
Curiously, ConA and ConBol stimulated (p<0.05) the growth of S. aureus (Figure 8c). 
ConBr did not demonstrate significant differences compared to the control (p>0.05). In 
opposition, higher concentrations of all lectins had antimicrobial activity (p<0.05) against S. 
epidermidis growth (Figure 8d). 
All lectins showed inhibitory activity (p<0.05) for C. albicans, but they enhanced the 
growth (p<0.05) of C. tropicalis, with exception of ConBr which had no significant effect 
(p>0.05). 
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Figure 8. Effect of lectins on bacteria and yeast planktonic growth (a – Pseudomonas aeruginosa; b - Klebsiella 
oxytoca; c – Staphylococcus aureus; d -  Staphylococcus epidermidis; e – Candida albicans; f – Candida tropicalis). 
*Statistically different from the control, 0 µg/mL (p < 0.05). 
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3.2. Bacteria and yeast early-stage adhesion 
To verify the effect of lectins on bacteria and yeast early-stage adhesion (Figure 9), 
microbial cells were put in contact with the range of concentrations of all lectins, during 2 h. 
After that, the biomass was quantified by CV, being the quantitative analysis performed 
through the measurement of the optical density at 570 nm.  
For P. aeruginosa (Figure 9a) when concentration of lectins was 250 µg/mL there was 
an increase of cell adhesion (p<0.05). However, lower concentrations of ConM and ConBol 
reduced it. In the case of K. oxytoca (Figure 9b) all lectins promoted an increase of cell 
adhesion (p<0.05).  
Cell adhesion of Gram-positive bacteria (Figure 9c and 9d) decreased in the presence 
of lectins (p<0.05). Conversely, C. albicans and C. tropicalis (Figure 9e and 9f) adhesion was 
enhanced (p<0.05). There was an exception for ConM (125 and 250 µg/mL), when in contact 
with C. tropicalis, being observed a reduction (p<0.05) of cell adhesion.  
 
3.3. Bacteria and yeast biofilm mass 
The interference of the presence of the lectins in the establishment of biofilms (24 h) 
was also assessed. For that, bacteria and yeast biofilm mass was quantified by CV staining, 
being quantitative analysis performed through the measurement of optical density at 570 nm 
(Figure 10). 
Biomass of P. aeruginosa (Figure 10a) decreased (p<0.05) in the presence of higher 
concentrations of ConBr and ConM, and intermediate concentration of ConBol. In contrast, for 
K. oxytoca (Figure 10b) all lectin enhanced (p<0.05) biofilm mass.  
ConBol was the only lectin to promote a decrease (p<0.05) of S. aureus biofilm mass 
(Figure 10c). But, the other lectins had no significant effect (p>0.05), compared with the 
control. Interestingly, the same lectins (ConA, ConBr and ConM) promoted a decrease (p<0.05) 
of S. epidermidis biofilm mass (Figure 10d), in lower concentrations. But, on the other hand, 
for higher concentrations of ConBr, ConM and ConBol there was an increase (p<0.05) of 
biofilm mass.  
In the case of C. albicans (Figure 10e), biofilm mass increased (p<0.05) for all 
concentrations and for all lectins, compared to the control. 
For C. tropicalis (Figure 10f), ConA (31.2 and 62.5 µg/mL), ConBr (125 and 250 µg/mL) 
and ConBol (125 µg/mL) showed inhibitory (p<0.05) activity. In contrast, ConA (250 µg/mL), 
ConBr (31.2 µg/mL), ConM (62.5 and 250 µg/mL) and ConBol (31.2 µg/mL) showed a 
stimulatory (p<0.05) effect. 
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Figure 9. Effect of lectins on bacteria and yeast early-stage adhesion (a – Pseudomonas aeruginosa; b - Klebsiella 
oxytoca; c – Staphylococcus aureus; d -  Staphylococcus epidermidis; e – Candida albicans; f – Candida tropicalis). 
*Statistically different from the control, 0 µg/mL (p < 0.05). 
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Figure 10. Bacteria and yeast biofilm formation (quantification of biofilm mass) in the presence of lectins (a – 
Pseudomonas aeruginosa; b - Klebsiella oxytoca; c – Staphylococcus aureus; d -  Staphylococcus epidermidis; e – 
Candida albicans; f – Candida tropicalis). *Statistically different from the control, 0 µg/mL (p < 0.05). 
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3.4. Bacteria and yeast viable biofilm-entrapped cells 
After 24 h of biofilm formation by bacteria and yeasts, the number of viable biofilm-
entrapped cells was also determined (Figure 11). 
An inhibitory effect (p<0.05) was observed for P. aeruginosa (Figure 11a), in the 
presence of 62.5 µg/mL of ConBol, whereas the other lectins had no effect (p>0.05). On the 
other hand, stimulatory effects (p<0.05) were found on K. oxytoca, in the presence of all 
studied lectins (Figure 11b).  
Similarly, there was a stimulatory effect (p<0.05) in the case of S. aureus (Figure 11c), 
whereas on S. epidermidis (Figure 11d) only ConBol promoted this effect. The other lectins had 
no effect on S. epidermidis (p>0.05). 
Regarding C. albicans (Figure 11e), ConA, ConBr and ConM induced a decrease 
(p<0.05) on the number of CFU, whereas ConBol had no significant effect (p>0.05). For C. 
tropicalis (Figure 11f), only ConM had no significant effect (p>0.05), compared to the control. 
The other lectins showed inhibitory activity (p<0.05). 
 
3.5. Summary table of results 
To better comprehend the results, it was created a table (Table 3) where they are 
represented in a condensed way. The effect of lectins on cells is represented by arrows. The 
direction of the arrows indicates the existence of an increase or inhibition of the condition 
which is being analyzed. 
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Figure 11. Bacteria and yeast biofilm formation (determination of the number of viable biofilm-entrapped cells) 
in the presence of lectins (a – Pseudomonas aeruginosa; b - Klebsiella oxytoca; c – Staphylococcus aureus; d -  
Staphylococcus epidermidis; e – Candida albicans; f – Candida tropicalis). *Statistically different from the control, 
0 µg/mL (p < 0.05).  
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Table 1. Summary table of results 
 
 
 Planktonic Growth Early-stage adhesion Biofilm mass Viable biofilm-entrapped cells 
 ConA ConBr ConM ConBol ConA ConBr ConM ConBol ConA ConBr ConM ConBol ConA ConBr ConM ConBol 
P. aeruginosa 
                
K. oxytoca                 
S. aureus                 
S. epidermidis      
           
C. albicans                 
C. tropicalis                 
Legend:  
- represents an increase;       
- represents a decrease; 
       - had no effect; 
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Antibacterial activity of lectins was expected, because mostly were isolated from 
storage parts of plants, suggesting their possible contribution to plant defense against 
pathogenic microorganisms and because they were used in folk medicine, for the treatments 
of diseases related with microbial infections (56) (58). In fact, when lectins bind to bacteria, 
agglutination and/or precipitation of bacteria can occur. This can influence bacterial motility 
(blocking) and afterwards can have an effect on their multiplication, inhibiting bacterial growth 
(56) (60). In the present study, the lectins tested did not show a significant inhibitory effect 
against the four bacteria studied. In fact, ConBol (Figure 8), for instances, had no effect on 
both Gram-negative bacteria (P.aeruginosa and K. oxytoca) and even increased the growth of 
S. aureus. Though, there was a small inhibition of the growth of bacteria with the high 
concentrations of the other lectins (250 µg/mL), except for S.aureus.  
Moreover, the high concentration tested (250 µg/mL) was a quite high value when 
compared with similar studies. In fact, Santi-Gadelha and colleagues (77) demonstrated that 
AaL lectin (150 µg/mL) had antibacterial activity against Gram-positive (Clavibacter 
michiganensis) and Gam-negative (Xanthomonas axonopodis) bacteria. Furthermore, Oliveira 
and colleagues (58) verified that EuniSL lectin inhibited the growth of S. aureus, P. aeruginosa 
and Klebsiela sp. with a minimum inhibitory concentration (MIC) of 1.5 µg/mL and inhibited 
the growth of B. subtilis, Streptococcus sp. and E. coli with a MIC of 16.5 µg/mL. However, 
Cavalcante and colleagues (80), when tested antimicrobial action of lectins from Diocleinae 
subtribe, have verified the need of a concentration of 500 µg/mL to inhibit S. mutans growth. 
Mostly microorganisms express surface-exposed carbohydrates and each one is a 
potential lectin-reactive site. The carbohydrates can be covalently bound, as in glycosylated 
teichoic acids to peptidoglycan, or non-covalently bound, as in capsular polysaccharides (77) 
(80). So, the differences that exist on surface-exposed carbohydrates of bacteria are 
responsible for the recognition of bacteria by lectins (80) (81).  
From the results obtained, it is possible to see that K. oxytoca is more sensitive than P. 
aeruginosa, because its growth was affected by lower concentrations of lectins. Moreover, 
results indicate an inhibition on S. epidermidis planktonic growth but not on the S. aureus 
(both Gram-positive bacteria). These differences between species, more evident than between 
Gram type, could be attributed to the different surface carbohydrates present on the different 
bacteria cell wall.  
All lectins used in this study are members of Diocleinae (Leguminosae) subfamily, 
being highly homologous (9) (67). 
Through analysis of Figure 8, it can be observed that although ConA and ConBr 
presented a similar effect on P. aeruginosa, K. oxytoca, S. epidermidis and C. albicans. For S. 
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aureus and C. tropicalis, ConA lectin stimulated the growth, whereas ConBr had no significant 
effect. These lectins are highly homologous, but they have distinct biological activities. ConBr 
had differences in quaternary structure in relation to ConA (quaternary structure is more open 
for ConBr than for ConA) that may constitute the structural basis for explaining their different 
biological activities (66) (67)  (89). The quaternary structure of Diocleinae lectins has relevant 
aspects as the subunit multivalency and the relative orientation of the carbohydrate-binding 
sites, that may explain their distinct biological activities (66). Besides variations on structure, 
the lectin ConBr may have not significant activity due the absence of proper ConBr 
glycoconjugates targets in the bacteria/fungal cell wall or cellular membrane, or inaccessibility 
of the lectin to the target (90).  
Lectins promoted an inhibition of the C. albicans growth, as observed on Figure 8. 
Plant lectins, such as lectins from Pisum sativum and from Capsicum annuum, revealed to be 
able to inhibit yeasts growth. Lectin from Pisum sativum was able to inhibit fungi like 
Aspergillus flavus and Trichoderma viride and lectin from Capsicum annuum was able to inhibit 
Aspergillus niger and Fuscarium solani, among others (81) (83).  In contrast, lectins promoted a 
stimulation of C. tropicalis (Figure 8). So, subtle structural differences in the surface 
glycoconjugates of these fungi species can affect the binding specificity of lectins (90). 
Antifungal activity was related to the lectin surface cell wall carbohydrate binding property, 
affecting activity and viability of fungal cells (81). Additionally, antifungal activity of some 
proteins or peptides was associated with chitin binding property (84). This binding property 
can simulate the carbohydrate binding property since chitin is composed of modified glucose 
subunits (N-acetyl glucose amine). Almost all lectins that bind glucose, equally recognize and 
interact with N-acetylglucosamine and even the acetamide group can increase the binding 
activity. Fungal cell wall can disrupt, increasing toxicity, when chitin binding occur, since chitin 
(major component of fungal wall) is a polymer of N-acetylglucosamine (81). Antifungal activity 
is important since, to date, only a small number of plant lectins have been described to really 
have this activity (57).  
Regarding adhesion (Figure 9), lectins had inhibitory effects on cell adherence for 
Gram-positive bacteria. Teixeira and colleagues (9) verified that the adhesion of some 
Streptococcus species (Gram-positive bacteria), such as Streptococcus mutans, Streptococcus 
oralis and Streptococcus mitis was inhibited by lectins like ConA, ConBr, lectins from Dioclea 
violacea (DVL) and from Dioclea grandiflora (DGL). Some concentrations of ConM and ConBol 
had the same inhibitory effect for P. aeruginosa (Figure 9a) and C. tropicalis (Figure 9f). The 
specific lectin-carbohydrate interaction between bacteria or fungal is one of the many 
molecular mechanisms involved in adherence of microorganisms, and consequent 
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development of biofilms. Specific ligands on the microorganisms’ surfaces appear to interact 
through diverse mechanisms, including cell-cell and substrate-cell interactions (61). Lectin 
binding on the microbial wall may block the available sites for exopolysaccharides, as well cell-
cell binding, and thus reduce attachment to the surface. Lectins can be used, being present in 
the milieu, to prevent the long-term attachment of bacteria on surfaces, and the consequent 
biofilm formation, because lectins are able to agglutinate bacteria (60).   
Biofilms are a structured community of surface-associated microbial cells enclosed in a 
self-produced polymeric matrix, forming a sessile population  (1) (37) (54) (91).  
Inside biofilms, cells undergo physiological changes in relation to individual planktonic 
cells. The extracellular matrix is composed, essentially, by exopolysaccharides and it is believed 
that it plays a key role in biofilm resistance (92) (93). EPS (mostly exopolysaccharides) are 
responsible for cell-cell and cell-surface interactions (94). 
Through analysis of Figure 10, it can be observed that the tested lectins promoted a 
decrease on biofilm mass of P. aeruginosa. Lectins from Marasmium oreades (MOA) and from 
Hippeastrum hybrid (HHA) have the capacity to bind, respectively, to galactose and mannose 
of the PsI (Polysaccharide synthesis locus) exopolysaccharide, which contributes to biofilm 
formation by P. aeruginosa. PsI is essential for bacterial adherence to a substratum (promote 
cell-cell and cell-surface interactions) and maintenance of biofim structure (95) (96).  
Although ConBr, ConM and ConBol promoted a decrease of biofilm mass for P. 
aeruginosa, as well as ConBol for S. aureus, there was no reduction of the viability of these 
bacteria (Figure 11 a and c). Islam and colleagues (60) verified an arrangement modification 
and absence of exopolysaccharide matrix when biofilms of S. mutans were treated with a 
lectin from Trigonella foenumgraecum (TFA). Their work revealed that cell-surface molecules, 
where lectins bind, can be involved in the maintenance of the arrangement and structural 
integrity of biofilms. Inhibition of adhesion and of consequent biofilm formation without 
affecting bacteria cells viability may prevent selective pressure and the development of 
microbial resistance (61).  
When lectins induce an enhancement of cell adhesion and biofilm biomass, but a 
decrease in the number of viable cells (Figures 9, 10, 11 e and f), it seems that lectins act by 
inducing a physiological change on cells rather than by a direct action on cells binding (92). 
Peumans and Van Damme (62) reported that cells of the intestine are capable of endocytosed 
PHA lectin. This lectin induces, when it enters the cells, an enhancement of the metabolic 
activity of the cells. Further studies should be performed to verify whether lectins are capable 
of being endocytosed by microbial cells and modify their metabolic activity. If this happens, 
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some phenomena, as enhancement of cell growth and biofilm development in the presence of 
lectins, will be probably better understood.  
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This study was conducted to verify whether dioclinae lectins had some effect on some 
bacteria and yeasts which are important nosocomial agents.  
The effect of lectins on microorganisms planktonic growth, early-stage adhesion and 
biofilm formation, inspected by, respectively, turbidimetry, quantification of adhered cells, 
biofilm biomass and the cultivate biofilm-growing cells, was evaluated.  
Through careful analysis of the results, it can be concluded that the tested lectins did 
not show a robust inhibitory effect against the microorganisms studied, being their activities 
different between species. The less significant antimicrobial activity occurred on K. oxytoca, 
because only its planktonic growth was inhibited by lectins.  
For Gram-positive bacteria, early-stage cell adhesion decreased in the presence of 
lectins, however enhanced for Candida species.    
The viability of the cultivated bacteria cells of the biofilms were not affected by lectins, 
whereas yeasts biofilm cells demonstrated to lose viability after exposure to lectins.  
Despite lectins demonstrate antimicrobial activity, it was also observed that some of 
them, for some microorganisms, promoted a stimulatory effect of growth, adhesion and 
biofilm formation. 
  Being lectins natural compounds with antimicrobial properties and high specificity, a 
continuous research to understand all mechanisms of their action is really important.  
So, research should be performed in order to verify whether lectins are capable of 
being endocytosed by microbial cells and modify their metabolic activity. 
To explore more exhaustively the potential action of lectins, an interesting approach 
using several lectins at the same time or lectins combined with conventional antibacterial and 
antifungal agents could be tested to verify whether there are some synergic effects. The use of 
several lectins at the same time will help to understand the interaction between lectins, when 
they act together.  
Additionally, microbial cells wall may be coated with mannose/glucose (specific 
monosaccharide for lectins used) to verify if there are an enhancement of lectin activity.  
The development of resistance to lectins or cross-resistance to other antimicrobial 
agents should be also studied.  
Further investigations must address the toxicity of these lectins regarding humans, for 
further applications on heath sector.  
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